These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22846992)

  • 41. Characterization of active and inactive states of CB1 receptor and the differential binding state modulation by cannabinoid agonists, antagonists and inverse agonists.
    Gullapalli S; Amrutkar D; Gupta S; Kandadi MR; Kumar H; Gandhi M; Karande V; Narayanan S
    Neuropharmacology; 2010 Jun; 58(8):1215-9. PubMed ID: 20214912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.
    Qiao CJ; Ali HI; Ahn KH; Kolluru S; Kendall DA; Lu D
    Eur J Med Chem; 2016 Oct; 121():517-529. PubMed ID: 27318976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of an allosteric modulator bound to the CB1 cannabinoid receptor.
    Shao Z; Yan W; Chapman K; Ramesh K; Ferrell AJ; Yin J; Wang X; Xu Q; Rosenbaum DM
    Nat Chem Biol; 2019 Dec; 15(12):1199-1205. PubMed ID: 31659318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model.
    Laprairie RB; Bagher AM; Rourke JL; Zrein A; Cairns EA; Kelly MEM; Sinal CJ; Kulkarni PM; Thakur GA; Denovan-Wright EM
    Neuropharmacology; 2019 Jun; 151():1-12. PubMed ID: 30940536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structures of agonist-bound human cannabinoid receptor CB
    Hua T; Vemuri K; Nikas SP; Laprairie RB; Wu Y; Qu L; Pu M; Korde A; Jiang S; Ho JH; Han GW; Ding K; Li X; Liu H; Hanson MA; Zhao S; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
    Nature; 2017 Jul; 547(7664):468-471. PubMed ID: 28678776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
    Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
    J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).
    Kulkarni PM; Kulkarni AR; Korde A; Tichkule RB; Laprairie RB; Denovan-Wright EM; Zhou H; Janero DR; Zvonok N; Makriyannis A; Cascio MG; Pertwee RG; Thakur GA
    J Med Chem; 2016 Jan; 59(1):44-60. PubMed ID: 26529344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications.
    Kulkarni AR; Garai S; Janero DR; Thakur GA
    Methods Enzymol; 2017; 593():281-315. PubMed ID: 28750808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
    Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
    Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor.
    Sabatucci A; Tortolani D; Dainese E; Maccarrone M
    Biotechnol Appl Biochem; 2018 Jan; 65(1):21-28. PubMed ID: 28833445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assay.
    Bruno A; Lembo F; Novellino E; Stornaiuolo M; Marinelli L
    Sci Rep; 2014 Jan; 4():3757. PubMed ID: 24441508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
    Brents LK; Gallus-Zawada A; Radominska-Pandya A; Vasiljevik T; Prisinzano TE; Fantegrossi WE; Moran JH; Prather PL
    Biochem Pharmacol; 2012 Apr; 83(7):952-61. PubMed ID: 22266354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.
    Khurana L; Mackie K; Piomelli D; Kendall DA
    Neuropharmacology; 2017 Sep; 124():3-12. PubMed ID: 28527758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity.
    Schaaf MJ; Cidlowski JA
    Mol Cell Biol; 2003 Mar; 23(6):1922-34. PubMed ID: 12612067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The In Vivo Effects of the CB
    Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation.
    Díaz Ó; Dalton JAR; Giraldo J
    J Med Chem; 2019 Jun; 62(11):5638-5654. PubMed ID: 31095906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
    Silva GB; Atchison DK; Juncos LI; García NH
    Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabinoid CB
    Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
    Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.